ASP Isotopes (NASDAQ:ASPI) and Mitsubishi Chemical (OTCMKTS:MTLHY) Critical Comparison

ASP Isotopes (NASDAQ:ASPI) and Mitsubishi Chemical (OTCMKTS:MTLHY) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.

Institutional & Insider Ownership

16.8% of ASP Isotopes shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

ASP Isotopes has a beta of 3.47, indicating that its stock price is 247% more volatile than the S&P 500. Comparatively, Mitsubishi Chemical has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.

Earnings & Valuation

This table compares ASP Isotopes and Mitsubishi Chemical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$4.14 million	146.05	-$32.33 million	($1.30)	-4.20
Mitsubishi Chemical	$28.94 billion	0.33	$297.13 million	$0.61	54.93

Mitsubishi Chemical has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Mitsubishi Chemical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares ASP Isotopes and Mitsubishi Chemical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-1,259.12%	-190.44%	-77.22%
Mitsubishi Chemical	0.62%	0.98%	0.38%

Analyst Ratings

This is a breakdown of recent ratings and target prices for ASP Isotopes and Mitsubishi Chemical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1	0	2	0	2.33
Mitsubishi Chemical	0	0	0	0	0.00

ASP Isotopes presently has a consensus price target of $13.00, suggesting a potential upside of 138.31%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, equities research analysts clearly believe ASP Isotopes is more favorable than Mitsubishi Chemical.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

About Mitsubishi Chemical

Mitsubishi Chemical Group Corporation provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally. It operates in five segments: Specialty Materials, Industrial Gases, Health Care, MMA, and Basic Materials. The Specialty Materials segment offers performance polymers, soarnol, gohsenol, sustainable polymers, and engineering plastics; coating materials, additives, and fines; packaging, industrial and medical, acetyl, and polyester films; engineering shapes and solutions, carbon fiber and composite materials, and fibers; aqua, life, and infrastructure solutions; and semiconductor, electronics, and battery materials. The Industrial Gases segment provides industrial gases. The Health Care segment offers ethical pharmaceuticals. The MMA segment provides methyl methacrylate (MMA) and polymethyl methacrylate (PMMA). The Basic Materials segment offers basic petrochemicals, polyolefins, and basic chemical derivatives, as well as carbon products. The company provides engineering, transportation, and warehousing services. Mitsubishi Chemical Group Corporation was incorporated in 2005 and is headquartered in Tokyo, Japan.